{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T05:52:43Z","timestamp":1763358763773},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T00:00:00Z","timestamp":1571097600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T00:00:00Z","timestamp":1571097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s12328-019-01053-y","type":"journal-article","created":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T20:48:01Z","timestamp":1571172481000},"page":"240-246","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Conversion surgery after extensive chemotherapy for stage IV mixed adenoneuroendocrine carcinoma (MANEC) of the gallbladder: clinical implications from the patterns of response and recurrence"],"prefix":"10.1007","volume":"13","author":[{"given":"Keiko","family":"Kamei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Shindoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Kiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ippei","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Takeyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,15]]},"reference":[{"issue":"Suppl 1","key":"1053_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000080731","volume":"80","author":"BG Taal","year":"2004","unstructured":"Taal BG, Visser O. Epidemiology of neuroendocrine tumours. Neuroendocrinology. 2004;80(Suppl 1):3\u20137.","journal-title":"Neuroendocrinology"},{"key":"1053_CR2","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/MPA.0b013e3181ec124e","volume":"39","author":"DS Klimstra","year":"2010","unstructured":"Klimstra DS, Modlin IR, Coppola D, et al. The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. Pancreas. 2010;39:707\u201312.","journal-title":"Pancreas"},{"key":"1053_CR3","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s12029-015-9745-9","volume":"46","author":"M Kamboj","year":"2015","unstructured":"Kamboj M, Gandhi JS, Gupta G, et al. Neuroendocrine carcinoma of gall bladder: a series of 19 cases with review of literature. J Gastrointest Cancer. 2015;46:356\u201364.","journal-title":"J Gastrointest Cancer"},{"key":"1053_CR4","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao JC, Hassan M, Phan A, et al. One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063\u201372.","journal-title":"J Clin Oncol"},{"key":"1053_CR5","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1097\/PAS.0000000000000882","volume":"41","author":"T Muraki","year":"2017","unstructured":"Muraki T, Memis B, Reid MD, et al. Reflux-Associated Cholecystopathy: Analysis of 76Reflux-associated cholecystopathy: analysis of 76 gallbladders from patients with supra-oddi union of the pancreatic duct and common bile duct (pancreatobiliary maljunction) elucidates a specific diagnostic pattern of mucosal hyperplasia as a prelude to carcinoma. Am J Surg Pathol. 2017;41:1167\u201377.","journal-title":"Am J Surg Pathol"},{"key":"1053_CR6","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.5858\/arpa.2015-0102-RS","volume":"140","author":"AM Acosta","year":"2016","unstructured":"Acosta AM, Wiley EL. Primary biliary mixed adenoneuroendocrine carcinoma (MANEC): a short review. Arch Pathol Lab Med. 2016;140:1157\u201362.","journal-title":"Arch Pathol Lab Med"},{"key":"1053_CR7","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1177\/1066896915580433","volume":"23","author":"AM Acosta","year":"2015","unstructured":"Acosta AM, Hamedani FS, Kajdacsy-Balla A, Wiley EL. Primary mixed adenoneuroendocrine carcinoma of the gallbladder in a 55-year-old female patient: a case report and review of the literature. Int J Surg Pathol. 2015;23:414\u20138.","journal-title":"Int J Surg Pathol"},{"key":"1053_CR8","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/pin.12188","volume":"64","author":"Y Meguro","year":"2014","unstructured":"Meguro Y, Fukushima N, Koizumi M, et al. A case of mixed adenoneuroendocrine carcinoma of the gallbladder arising from an intracystic papillary neoplasm associated with pancreaticobiliary maljunction. Pathol Int. 2014;64:465\u201371.","journal-title":"Pathol Int"},{"key":"1053_CR9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.5009\/gnl.2009.3.3.231","volume":"3","author":"KW Yoon","year":"2009","unstructured":"Yoon KW, Park CH, Lee WS, et al. A case of primary neuroendocrine carcinoma of the gallbladder associated with anomalous union of the pancreaticobiliary duct. Gut Liver. 2009;3:231\u20134.","journal-title":"Gut Liver"},{"key":"1053_CR10","first-page":"1348","volume":"112","author":"Y Michikawa","year":"2015","unstructured":"Michikawa Y, Horaguchi J, Noda Y, et al. [Mixed adenoneuroendocrine carcinoma of the gallbladder diagnosed by endoscopic transpapillary catheterization using bile cytology assessed by the cell block method]. Nihon Shokakibyo Gakkai Zasshi. 2015;112:1348\u201356.","journal-title":"Nihon Shokakibyo Gakkai Zasshi"},{"key":"1053_CR11","unstructured":"Soga J. Primary endocrinomas (carcinoids and variant neoplasms) of the gallbladder. A statistical evaluation of 138 reported cases. J Exp Clin Cancer Res 2003; 22: 5\u201315."},{"key":"1053_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00428-012-1212-4","volume":"460","author":"K Harada","year":"2012","unstructured":"Harada K, Sato Y, Ikeda H, et al. Clinicopathologic study of mixed adenoneuroendocrine carcinomas of hepatobiliary organs. Virchows Arch. 2012;460:281\u20139.","journal-title":"Virchows Arch"},{"key":"1053_CR13","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","volume":"27","author":"A Rinke","year":"2009","unstructured":"Rinke A, Muller HH, Schade-Brittinger C, et al. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol. 2009;27:4656\u201363.","journal-title":"J Clin Oncol"},{"key":"1053_CR14","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1056\/NEJMoa1009290","volume":"364","author":"JC Yao","year":"2011","unstructured":"Yao JC, Shah MH, Ito T, et al. Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med. 2011;364:514\u201323.","journal-title":"N Engl J Med"},{"key":"1053_CR15","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1056\/NEJMoa1003825","volume":"364","author":"E Raymond","year":"2011","unstructured":"Raymond E, Dahan L, Raoul JL, et al. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med. 2011;364:501\u201313.","journal-title":"N Engl J Med"},{"key":"1053_CR16","unstructured":"Plockinger U, Rindi G, Arnold R et al. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology 2004;80:394-424."},{"key":"1053_CR17","doi-asserted-by":"publisher","first-page":"11916","DOI":"10.3748\/wjg.v20.i33.11916","volume":"20","author":"H Chen","year":"2014","unstructured":"Chen H, Shen YY, Ni XZ. Two cases of neuroendocrine carcinoma of the gallbladder. World J Gastroenterol. 2014;20:11916\u201320.","journal-title":"World J Gastroenterol"},{"key":"1053_CR18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/1746-1596-7-163","volume":"7","author":"W Song","year":"2012","unstructured":"Song W, Chen W, Zhang S, et al. Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy. Diagn Pathol. 2012;7:163.","journal-title":"Diagn Pathol"},{"key":"1053_CR19","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/sj.bjc.6690325","volume":"81","author":"E Mitry","year":"1999","unstructured":"Mitry E, Baudin E, Ducreux M, et al. Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin. Br J Cancer. 1999;81:1351\u20135.","journal-title":"Br J Cancer"},{"key":"1053_CR20","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s11605-017-3359-4","volume":"21","author":"K Tani","year":"2017","unstructured":"Tani K, Shindoh J, Takamoto T, et al. Kinetic changes in liver parenchyma after preoperative chemotherapy for patients with colorectal liver metastases. J Gastrointest Surg. 2017;21:813\u201321.","journal-title":"J Gastrointest Surg"},{"key":"1053_CR21","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/jso.21141","volume":"98","author":"A Duffy","year":"2008","unstructured":"Duffy A, Capanu M, Abou-Alfa GK, et al. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol. 2008;98:485\u20139.","journal-title":"J Surg Oncol"},{"key":"1053_CR22","doi-asserted-by":"publisher","first-page":"712","DOI":"10.6004\/jnccn.2009.0050","volume":"7","author":"OH Clark","year":"2009","unstructured":"Clark OH, Benson AB 3rd, Berlin JD, et al. NCCN clinical practice guidelines in oncology: neuroendocrine tumors. J Natl Compr Canc Netw. 2009;7:712\u201347.","journal-title":"J Natl Compr Canc Netw"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-019-01053-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12328-019-01053-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-019-01053-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T23:41:54Z","timestamp":1602632514000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12328-019-01053-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,15]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1053"],"URL":"https:\/\/doi.org\/10.1007\/s12328-019-01053-y","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,15]]},"assertion":[{"value":"23 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Rights"}},{"value":"Informed consent was obtained from the patient for being included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}